TARSA THERAPEUTICS, INC.

Profile

Company Names

TARSA THERAPEUTICS, INC.

Addresses

8 PENN CENTER, 1628 JFK BLVD. SUITE 1400, PHILADELPHIA, PA 19103

8 PENN CENTER, 1628 JFK BLVD SUITE 1400, PHILADELPHIA, PA 19103

8 PENN CENTER, 1628 JOHN F. KENNEDY BLVD, STE. 1400, PHILADELPHIA, PA 19103-2124

8 PENN CENTER, PHILADELPHIA, PA 19103

45 SCHOOL STREET, BOSTON, MA 02108

Phone Numbers

267-273-7940
6173832101

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$46,753,682.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2017-07-07 
$549,858.00 
$1,000,000.00 
$450,142.00 
Debt 
6
2016-12-29 
$1,635,967.00 
$1,636,000.00 
$33.00 
Debt 
5
2016-06-29 
$1,250,000.00 
$1,250,000.00 
$0.00 
Debt 
4
2016-02-05 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
3
2012-03-13 
$13,767,857.00 
$28,000,000.00 
$14,232,143.00 
Equity 
2
2010-09-29 
$15,500,000.00 
$24,500,000.00 
$9,000,000.00 
Debt 
1
2009-10-19 
$12,050,000.00 
$24,100,000.00 
$12,050,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERIC 
 
BEDNARSKI 
DIRECTOR
DAVID 
 
BRAND 
EXECUTIVE OFFICER, DIRECTOR
RICHARD 
 
KOLLENDER 
DIRECTOR
GREGORY 
 
LUMPKIN 
EXECUTIVE OFFICER
MATTHEW 
 
RIEKE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-07-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#